FDA approves first treatment for inherited rare disease
The approval of the drug, Givlaari was based on the results of a clinical trial of 94 patients with acute hepatic porphyria
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
US Food and Drug Administration
FDA approves new breakthrough therapy for cystic fibrosis
Treatment approved for approximately 90 per cent of patients with cystic fibrosis, many of whom had no approved therapeutic…
Eli Lilly’s migraine treatment wins US FDA approval
The drug has been approved to treat acute migraine with or without aura, a sensory phenomenon or visual disturbance, in adults
Sun Pharma launches CEQUA for treatment of dry eye disease in US
Sun Pharma introduces CEQUA SUPPORTTM Specialty Pharmacy programme to enable easy access for patients to obtain treatment
Sun…
FDA awards 12 grants to fund new clinical trials
To advance the development of medical products for the treatment of rare diseases mainly those affecting children and cancers…
IIT Hyderabad develops oral tablets for treatment of fungal infections,‘Kala Azar’
The tablets could help in better management of disease burden in country
US FDA finds “significant violations” at India’s Strides plant
The drugmaker was caught trying to dispose quality-control records, the FDA said in a letter made public on July 16
FDA pulls up Aurobindo Pharma for ‘repeated’ failures in CGMP
The FDA recently issued a letter warning the drug- makers unit X1 in Srikakulam district of Andhra Pradesh for deviations from…
Building quality excellence in pharma industry
With the pharma industry expanding scale and complexity, quality has emerged as a major focus area. Is quality merely a risk to be…
Cadila gets US FDA nod to sell generic anti-viral drug
The drugs will be manufactured in Ahmedabad